SUTRO BIOPHARMA, INC.

STRONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$102.5M

▲ 65.2% YoY

Net Income

-$191.1M

▲ 16.0% YoY

EPS

$-22.49

▲ 23.5% YoY

Cash

$58.1M

▼ 69.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.